Title : Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

Pub. Date : 1997 Dec

PMID : 9407424






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Angiotensin-converting-enzyme Inhibition on Progressive Renal Insufficiency (AIPRI) Study showed that the ACE inhibitor benazepril provides protection against loss of renal function in patients with chronic renal insufficiency (CRI) caused by various renal diseases. benazepril angiotensin I converting enzyme Homo sapiens
2 The Angiotensin-converting-enzyme Inhibition on Progressive Renal Insufficiency (AIPRI) Study showed that the ACE inhibitor benazepril provides protection against loss of renal function in patients with chronic renal insufficiency (CRI) caused by various renal diseases. benazepril angiotensin I converting enzyme Homo sapiens
3 Many patients from both treatment groups (64% on benazepril and 61% on placebo) received ACE inhibitors during follow-up. benazepril angiotensin I converting enzyme Homo sapiens